Track topics on Twitter Track topics that are important to you
Informally, FDA appears open to trials that use cognition as the only primary endpoint rather than insisting that products also...
Original Article: FDA Should Let Alzheimer’s Trials Rely On Single Endpoint, Group SaysNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...